+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eczema Drug"

US Eczema Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Eczema Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Global Eczema Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Eczema Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Dermatitis (Eczema) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Dermatitis (Eczema) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 1197 Pages
  • Global
From
From
From
From
From
United Arab Emirates Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
Loading Indicator

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition. Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more